Literature DB >> 6476589

Hemodynamics of patients with severe chronic obstructive pulmonary disease during progressive upright exercise.

R W Light, H M Mintz, G S Linden, S E Brown.   

Abstract

This study evaluated the relationship between the oxygen consumption (VO2) and cardiac output and heart rate during progressive exercise in the upright position in 26 patients with severe chronic obstructive pulmonary disease. Forced expiratory volume in one second (FEV1) was 0.82 +/- 0.21 L, and single-breath carbon monoxide diffusing capacity was 39 +/- 20% predicted. Cardiac outputs were measured by the direct Fick method. The patients as a group had a normal cardiac output for the level of VO2. The mean pulmonary artery pressure in our patients (22.5 +/- 10.1 mmHg) was increased at rest; during exercise, it increased abnormally to 45.5 +/- 18.9 mmHg. The heart rates were increased both at rest and during exercise, and the increase in heart rate for an increase in VO2 was higher than normal. The relative tachycardia observed was probably related to a combination of abnormal arterial blood gases, concomitant bronchodilator administration, deconditioning, and right ventricular dysfunction. The relative tachycardia did not appear to have an adverse effect on exercise tolerance because the ratio of maximal exercise ventilation to the FEV1 exceeded 35 in those patients with observed maximal heart rates above 90% of predicted. The results of this study suggest that improvements in the exercise tolerance of these patients is dependent upon improving their ventilatory capabilities or the efficacy of their ventilation.

Entities:  

Mesh:

Year:  1984        PMID: 6476589     DOI: 10.1164/arrd.1984.130.3.391

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  8 in total

1.  Impaired central hemodynamics in chronic obstructive pulmonary disease during submaximal exercise.

Authors:  Joshua R Smith; Bruce D Johnson; Thomas P Olson
Journal:  J Appl Physiol (1985)       Date:  2019-07-11

2.  Influence of respiratory pressure support on hemodynamics and exercise tolerance in patients with COPD.

Authors:  Cristino Carneiro Oliveira; Cláudia Regina Carrascosa; Audrey Borghi-Silva; Danilo C Berton; Fernando Queiroga; Eloara M V Ferreira; Luiz E Nery; J Alberto Neder; J Alberto Neder
Journal:  Eur J Appl Physiol       Date:  2010-03-06       Impact factor: 3.078

Review 3.  COPD exacerbations . 3: Pathophysiology.

Authors:  D E O'Donnell; C M Parker
Journal:  Thorax       Date:  2006-04       Impact factor: 9.139

4.  Vasodilators in pulmonary hypertension.

Authors:  A Peacock
Journal:  Thorax       Date:  1993-12       Impact factor: 9.139

5.  Heart-lung interaction in a model of COPD: importance of lung volume and direct ventricular interaction.

Authors:  William S Cheyne; Alexandra M Williams; Megan I Harper; Neil D Eves
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-10-07       Impact factor: 4.733

6.  Lung deflation and oxygen pulse in COPD: results from the NETT randomized trial.

Authors:  Carolyn E Come; Miguel J Divo; Raúl San José Estépar; Frank C Sciurba; Gerard J Criner; Nathaniel Marchetti; Steven M Scharf; Zab Mosenifar; Barry J Make; Cesar A Keller; Omar A Minai; Fernando J Martinez; MeiLan K Han; John J Reilly; Bartolome R Celli; George R Washko
Journal:  Respir Med       Date:  2011-08-16       Impact factor: 3.415

Review 7.  Pathogenesis of hyperinflation in chronic obstructive pulmonary disease.

Authors:  Philippe Gagnon; Jordan A Guenette; Daniel Langer; Louis Laviolette; Vincent Mainguy; François Maltais; Fernanda Ribeiro; Didier Saey
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-02-15

Review 8.  Advances in the Evaluation of Respiratory Pathophysiology during Exercise in Chronic Lung Diseases.

Authors:  Denis E O'Donnell; Amany F Elbehairy; Danilo C Berton; Nicolle J Domnik; J Alberto Neder
Journal:  Front Physiol       Date:  2017-02-22       Impact factor: 4.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.